Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is common both in obese and overweight patients. Fibroblast growth factor 19 (FGF19), an intestinal hormone, could play a role in the complex pathogenesis of NAFLD. The aim of our study was to investigate responses of FGF19 and bile acid (BA) syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedrich, Dana, Marschall, Hanns-Ulrich, Lammert, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987457/
https://www.ncbi.nlm.nih.gov/pubmed/29866129
http://dx.doi.org/10.1186/s12876-018-0805-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987457/
https://www.ncbi.nlm.nih.gov/pubmed/29866129
http://dx.doi.org/10.1186/s12876-018-0805-z

Ejemplares similares